Protein kinase B/Akt signalling is required for palmitate-induced β-cell lipotoxicity

Diabetes, Obesity and Metabolism

Volumn 8, Issue 2, 2006, Pages 228-233

  Higa, M ^a   Shimabukuro, Michio ^a   Shimajiri, Y ^a   Takasu, N ^a   Shinjyo, T ^a   Inaba, T ^b  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Free fatty acid; Lipotoxicity; Protein kinase B Akt

Indexed keywords

EOSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLEIC ACID; PALMITIC ACID; PROTEIN KINASE B;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; CELL COUNT; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GEL MOBILITY SHIFT ASSAY; IMMUNOBLOTTING; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 33646002042     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00488.x     Document Type: Article

References (17)

1. De fronzo RA. The triumvirate β-cell, muscle, liver: A collusion responsible for NIDDM. Diabetes 1998; 37: 667-687.
2. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 1995; 44: 863-870.
3. Unger RH. How obesity causes diabetes in Zucker diabetic fatty rats. Trends Endocrinol Metab 1997; 8: 276-281.
4. Shimabukuro M, Ohneda M, Lee Y, Unger RH. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 1997; 100: 290-295.
5. Shimabukuro M, Zhou Y-T, Levi M, Unger RH. Fatty acid-induced β cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95: 2498-2502.
6. Shimabukuro M, Wang M-Y, Zhou Y-T, Newgard CB, Unger RH. Protection against lipoapoptosis of β cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA 1998; 95: 9558-9561.
7. McGarry JD. What if minkowski had been ageusic? An alternative angle on diabetes. Science 1992; 258: 766-770.
8. Lingohr MK, Buettner R, Rhodes CJ. Pancreatic β-cell growth and survival - a role in obesity-linked type 2 diabetes? Trends Mol Med 2002; 8: 375-384.
9. Tuttle RL, Gill NS, Pugh W et al. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKB. Nature Med 2001; 7: 1133-1137.
10. Shinjyo T, Kuribara R, Inukai T et al. Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors. Mol Cell Biol 2001; 21: 854-864.
11. Shimajiri Y, Sanke T, Furuta H et al. A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese. Diabetes 2001; 50: 2864-2869.
12. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY. Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function. Diabetes 2001; 50: 69-76.
13. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet β cell expression of constitutively active Akt1/PKB induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001; 108: 1631-1638.
14. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kB transcription factors. Oncogene 1999; 18: 6910-6924.
15. Cardozo AK, Kruhøffer M, Leeman R, Ørtonft T, Eizirik DL. Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 2001; 50: 909-920.
16. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 1999; 401: 86-90.
17. Foo SY, Nolan GP. NF-kB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 1999; 15: 229-235.